Loading patent…
AssigneeNovavax, Inc.
InventorsGale SMITH, Rick BRIGHT, Peter PUSHKO, Jinyou ZHANG, Kutub MAHMOOD
Estimating the term…
The present invention discloses and claims virus like particles (VLPs) that express and/or contains seasonal influenza virus proteins, avian influenza virus proteins and/or influenza virus proteins from viruses with pandemic potential. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing substantial immunity to either seasonal and avian influenza, or at least one symptom thereof.
A vaccine comprising an influenza virus-like particle (VLP) and a pharmaceutically acceptable carrier or excipient, wherein the VLP comprises influenza M1, HA and NA proteins, wherein the vaccine induces substantial immunity to influenza virus infection in an animal susceptible to influenza,
A method of formulating a vaccine that induces substantial immunity to influenza virus infection to an animal susceptible to influenza, comprising adding an effective dose of an influenza virus-like particle (VLP) to a pharmaceutically acceptable carrier or excipient, wherein the VLP comprises influenza M1, HA and NA proteins, wherein the vaccine induces substantial immunity to influenza virus infection to the animal
A virus-like particle (VLP) comprising an influenza virus M1 protein, an influenza virus H7 hemagglutinin protein, and an influenza virus N9 neuraminidase protein, wherein the M1 protein is derived from the influenza strain A/Indonesia/5/05.
Dependencies are inferred from the claim text.